Jeong Ho Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jeong Ho Hwang has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Hoon Taek Lee
Department of Animal Biotechnology, Bio-Organ Research Center/Animal Resources Research Center, Konkuk University, Seoul, South Korea
11 shared publications Young Kyu Kim
Large Animal Convergence Research Center, Korea Institute of Toxicology, Jeongeup, South Korea
9 shared publicationsJu Young Lee
Center for Large Animals Convergence Research, Korea Institute of Toxicology, Jeongeup, Republic of Korea
8 shared publicationsGuneswar Sethi
Animal Biotechnology and Genomics Division, National Institute of Animal Science, Rural Development Administration Jeonbuk State Republic of Korea
7 shared publicationsMi-Jin Yang
Korea Institute of Toxicology, Jeongeup, Republic of Korea
7 shared publicationsGoo-Hwa Kang
Division of Jeonbuk Advanced Bio Research, Korea Institute of Toxicology, Jeongeup, Republic of Korea
6 shared publications
Latest Publications
- Open Access
- 22 September 2026
- Published by Springer Nature in Scientific Data
Multi-omic landscape of a porcine SCID model with a single-codon RAG2 deletion
- 22 September 2026
- Published by Springer Nature in Scientific Data
Open AccessMulti-omic landscape of a porcine SCID model with a single-codon RAG2 deletion
- Open Access
- 7 September 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 40 (3) , 339-353
Beyond immune rejection: integrative genetic engineering strategies for overcoming coagulopathy in xenotransplantation
Jeong Ho Hwang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.26.0044
- 7 September 2026
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 40 (3) , 339-353
Open AccessBeyond immune rejection: integrative genetic engineering strategies for overcoming coagulopathy in xenotransplantation
Jeong Ho Hwang. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.26.0044
- Open Access
- 14 August 2026
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 31 (4)
ε-Viniferin Attenuates LPS-Induced Inflammatory Activation in Canine Macrophages by Regulating NF-κB and MAPK Pathways
- 14 August 2026
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 31 (4)
Open Accessε-Viniferin Attenuates LPS-Induced Inflammatory Activation in Canine Macrophages by Regulating NF-κB and MAPK Pathways
- Open Access
- 21 July 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (1)
Discovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches
The global spread of drug‐resistant Plasmodium falciparum , particularly artemisinin‐resistant strains, underscores the urgent need for novel antimalarial agents with distinct mechanisms of action and improved therapeutic potential. In this study, we employed an integrated in silico and in vitro strategy to identify compounds with inhibitory activity against P. falciparum apicoplast Gyrase B (PfGyrB). High‐throughput virtual screening identified hit compounds with favorable predicted interactions against the target protein, which were subsequently evaluated using biochemical ATPase inhibition and parasite growth inhibition assays. UNC8153 and Fexofenadine hydrochloride demonstrated time‐dependent antiplasmodial activity, with lower IC 50 values at 96 h than at 48 h under prolonged exposure conditions. UNC8153 exhibited greater antiplasmodial activity (~25‐fold) than the reference compound novobiocin during the second intraerythrocytic cycle. Morphological analysis indicated impaired parasite development during the second intraerythrocytic cycle under prolonged exposure conditions. Importantly, UNC8153 retained inhibitory activity against the artemisinin‐resistant C580Y strain and exhibited minimal cytotoxicity toward HEK‐293 cells under the tested experimental conditions. Structural similarity analysis indicated that the identified compounds are chemically distinct from currently used antimalarial drugs, supporting their structural novelty. Collectively, these findings identify UNC8153 as a structurally distinct new antiplasmodial scaffold warranting further mechanistic, pharmacological, and in vivo evaluation.
- 21 July 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 108 (1)
Open AccessDiscovery of Potent Antimalarial Agents Targeting Plasmodium falciparum DNA Gyrase B by Integrating Computational and Experimental Approaches
The global spread of drug‐resistant Plasmodium falciparum , particularly artemisinin‐resistant strains, underscores the urgent need for novel antimalarial agents with distinct mechanisms of action and improved therapeutic potential. In this study, we employed an integrated in silico and in vitro strategy to identify compounds with inhibitory activity against P. falciparum apicoplast Gyrase B (PfGyrB). High‐throughput virtual screening identified hit compounds with favorable predicted interactions against the target protein, which were subsequently evaluated using biochemical ATPase inhibition and parasite growth inhibition assays. UNC8153 and Fexofenadine hydrochloride demonstrated time‐dependent antiplasmodial activity, with lower IC 50 values at 96 h than at 48 h under prolonged exposure conditions. UNC8153 exhibited greater antiplasmodial activity (~25‐fold) than the reference compound novobiocin during the second intraerythrocytic cycle. Morphological analysis indicated impaired parasite development during the second intraerythrocytic cycle under prolonged exposure conditions. Importantly, UNC8153 retained inhibitory activity against the artemisinin‐resistant C580Y strain and exhibited minimal cytotoxicity toward HEK‐293 cells under the tested experimental conditions. Structural similarity analysis indicated that the identified compounds are chemically distinct from currently used antimalarial drugs, supporting their structural novelty. Collectively, these findings identify UNC8153 as a structurally distinct new antiplasmodial scaffold warranting further mechanistic, pharmacological, and in vivo evaluation.
- Open Access
- 10 June 2026
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 31 (3)
Freeze-Dried Extracts of Eruca sativa Selectively Inhibit Nuclear Factor-κB and Vascular Endothelial Growth Factor Levels in Retinal Pigment Epithelial Cells
Diabetic retinopathy and age-related macular degeneration are driven by retinal pigment epithelium (RPE) dysfunction accompanied by chronic inflammation and an upregulation of vascular endothelial growth factor (VEGF). This study investigated the protective effects of Eruca sativa freeze-dried extract against metabolic and inflammatory stress in the ARPE-19 retinal epithelial cell line. Gene expression levels and protein contents were assessed via quantitative real-time polymerase chain reaction and Western blots. VEGF secretion and cell calcium levels were quantified using enzyme-linked immunosorbent assay and Fluo-4 NW calcium assay, respectively. Freeze-dried E. sativa extract (ESF) exposure did not induce any cytotoxicity across the concentration range tested. Under thapsigargin (Tg) stimulation, ESF at 1 mg/mL significantly reduced VEGF expression and protein secretion by 32% and 34%, respectively. Tg-induced calcium mobilization within cells and the expression of unfolded protein response markers, including CCAAT/enhancer-binding protein homologous protein, binding immunoglobulin protein, and X-box binding protein-1, remained unchanged following ESF exposure. Under lipopolysaccharide stimulation, in a dose-dependent manner, ESF suppressed nuclear factor-κB (NF-κB) phosphorylation, tumor necrosis factor-α, and interleukin-1β expression; however, c-Jun N-terminal kinase signaling was not affected. Hot-air-dried E. sativa extract demonstrated contrasting regulatory profiles, which exhibited a broader modulation of endoplasmic reticulum stress and mitogen-activated protein kinase signaling. Collectively, the findings demonstrate that ESF selectively attenuates inflammatory and angiogenic responses by specifically inhibiting the NF-κB-VEGF axis. Dehydration, therefore, is a critical method determining ESF bioactivity, preserving native phytochemicals that confer focused anti-inflammatory and anti-angiogenic efficacy in RPE cells.
- 10 June 2026
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 31 (3)
Open AccessFreeze-Dried Extracts of Eruca sativa Selectively Inhibit Nuclear Factor-κB and Vascular Endothelial Growth Factor Levels in Retinal Pigment Epithelial Cells
Diabetic retinopathy and age-related macular degeneration are driven by retinal pigment epithelium (RPE) dysfunction accompanied by chronic inflammation and an upregulation of vascular endothelial growth factor (VEGF). This study investigated the protective effects of Eruca sativa freeze-dried extract against metabolic and inflammatory stress in the ARPE-19 retinal epithelial cell line. Gene expression levels and protein contents were assessed via quantitative real-time polymerase chain reaction and Western blots. VEGF secretion and cell calcium levels were quantified using enzyme-linked immunosorbent assay and Fluo-4 NW calcium assay, respectively. Freeze-dried E. sativa extract (ESF) exposure did not induce any cytotoxicity across the concentration range tested. Under thapsigargin (Tg) stimulation, ESF at 1 mg/mL significantly reduced VEGF expression and protein secretion by 32% and 34%, respectively. Tg-induced calcium mobilization within cells and the expression of unfolded protein response markers, including CCAAT/enhancer-binding protein homologous protein, binding immunoglobulin protein, and X-box binding protein-1, remained unchanged following ESF exposure. Under lipopolysaccharide stimulation, in a dose-dependent manner, ESF suppressed nuclear factor-κB (NF-κB) phosphorylation, tumor necrosis factor-α, and interleukin-1β expression; however, c-Jun N-terminal kinase signaling was not affected. Hot-air-dried E. sativa extract demonstrated contrasting regulatory profiles, which exhibited a broader modulation of endoplasmic reticulum stress and mitogen-activated protein kinase signaling. Collectively, the findings demonstrate that ESF selectively attenuates inflammatory and angiogenic responses by specifically inhibiting the NF-κB-VEGF axis. Dehydration, therefore, is a critical method determining ESF bioactivity, preserving native phytochemicals that confer focused anti-inflammatory and anti-angiogenic efficacy in RPE cells.
- Open Access
- 31 May 2026
- Published by Korean Society of Animal Science and Technology in Journal of Animal Science and Technology
- Vol. 68 (3) , 889-903
Characteristics between porcine bone marrow-derived mesenchymal stem and peripheral blood mononuclear cells
Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.
- 31 May 2026
- Published by Korean Society of Animal Science and Technology in Journal of Animal Science and Technology
- Vol. 68 (3) , 889-903
Open AccessCharacteristics between porcine bone marrow-derived mesenchymal stem and peripheral blood mononuclear cells
Journal of Animal Science and Technology (JAST) is a peer-reviewed, open access journal publishing original research, review articles and notes in all fields of animal science. Topics covered by the journal include: genetics and breeding, physiology, nutrition of monogastric animals, nutrition of ruminants, animal products (milk, meat, eggs and their by-products) and their processing, grasslands and roughages, livestock environment, animal biotechnology, animal behavior and welfare.
- Open Access
- 2 February 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1733096
Computational identification of natural inhibitors targeting GroEL in Leptospira interrogans: an integrative virtual screening and molecular dynamics approach
Introduction: Leptospirosis is a zoonotic disease caused by Leptospira interrogans and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target. Methods: A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand–protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity. Results: Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from −10.34 to −8.26 kcal/mol. All shortlisted compounds complied with Lipinski’s Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand–protein interactions. Among the candidates, F1864–0208 and F1243–0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition. Discussion: This study provides computational evidence supporting GroEL as a viable drug target in L. interrogans . The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further in vitro and in vivo studies are required to validate their therapeutic efficacy and safety.
- 2 February 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1733096
Open AccessComputational identification of natural inhibitors targeting GroEL in Leptospira interrogans: an integrative virtual screening and molecular dynamics approach
Introduction: Leptospirosis is a zoonotic disease caused by Leptospira interrogans and represents a major public health and veterinary concern. The persistence of the pathogen is closely associated with biofilm formation, yet targeted therapeutics are currently unavailable. The GroEL chaperonin, a conserved protein involved in biofilm formation and immunogenicity, was investigated as a potential therapeutic target. Methods: A structure-based virtual screening approach was performed using a library of 543,503 natural compounds from the Life Chemicals database. Top-ranked ligands were evaluated using molecular docking and physicochemical and pharmacokinetic property analyses. Density functional theory calculations were performed to assess electronic stability, followed by molecular dynamics simulations to evaluate ligand–protein complex stability. Principal component analysis and MM-PBSA binding free energy calculations were subsequently applied to characterize conformational dynamics and binding affinity. Results: Five compounds (F3385-2019, F1243-0200, F3139-0927, F2801-0179, and F1864-0208) exhibited strong binding affinities toward GroEL, with docking energies ranging from −10.34 to −8.26 kcal/mol. All shortlisted compounds complied with Lipinski’s Rule of Five and demonstrated favorable pharmacokinetic properties. Molecular dynamics simulations and MM-PBSA analyses indicated stable ligand–protein interactions. Among the candidates, F1864–0208 and F1243–0200 emerged as the most stable and promising leads, whereas the remaining compounds showed moderate inhibition. Discussion: This study provides computational evidence supporting GroEL as a viable drug target in L. interrogans . The identified natural compounds may represent promising scaffolds for the development of novel anti-leptospiral agents. Further in vitro and in vivo studies are required to validate their therapeutic efficacy and safety.
- 11 January 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 341 (Pt 1) , 150231
The effect of alginate on in vitro and in vivo behaviors of ticagrelor self-microemulsifying drug delivery system
- 11 January 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 341 (Pt 1) , 150231
The effect of alginate on in vitro and in vivo behaviors of ticagrelor self-microemulsifying drug delivery system
- Open Access
- 16 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Hemolysis-induced hepatic ferroptosis following xenotransfusion of genetically modified pig red blood cells
To overcome cross-species immunological barriers, researchers utilize gene editing to remove the expression of three major carbohydrate xenoantigens ( α-Gal , Neu5Gc , and Sd(a) ) and insert genes, such as human protective genes ( hCD55 and hCD39 ). This study aimed to investigate the mechanisms underlying long-term hepatic injury following xenotransfusion of genetically modified pig red blood cells (pRBCs). We xenotransfused pRBCs genetically engineered with GGTA1 −/− ( α-Gal −) ; CMAH −/− ( Neu5Gc − ); β4GALNT2 −/− ( Sd(a) − ) ; hCD55; hCD39 into a non-human primate (NHP) model of acute hemorrhage hemolysis and evaluated the long-term immune response to xenogeneic RBCs in the liver, a key organ for RBC metabolism. Immediately after xenotransfusion (D + 1), significant elevations of liver enzymes (AST, ALT) and iron-related factors were observed in the serum levels of the recipients, which were normalized by D + 21. However, long-term analysis revealed excessive accumulation of iron ions in the liver and decreased expression of antioxidant enzymes. The resulting endoplasmic reticulum stress (increased GRP78/BiP expression), lipid peroxide accumulation, and iron-dependent cell death (ferroptosis) persisted in the liver of the recipient. These results suggest that, beyond gene editing, additional hurdles must be overcome to completely block oxidative stress damage caused by impaired RBC lysis. Notably, transcriptomic and immunohistochemical analyses in the NHP model identified the direct role of ferroptosis in xenotransfusion-induced liver injury. Therefore, we propose that a multilayered approach, including blocking the ROS-Iron axis and administering ferroptosis inhibitors, is needed to ensure long-term safety in the clinical development of xenotransfusion.
- 16 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Open AccessHemolysis-induced hepatic ferroptosis following xenotransfusion of genetically modified pig red blood cells
To overcome cross-species immunological barriers, researchers utilize gene editing to remove the expression of three major carbohydrate xenoantigens ( α-Gal , Neu5Gc , and Sd(a) ) and insert genes, such as human protective genes ( hCD55 and hCD39 ). This study aimed to investigate the mechanisms underlying long-term hepatic injury following xenotransfusion of genetically modified pig red blood cells (pRBCs). We xenotransfused pRBCs genetically engineered with GGTA1 −/− ( α-Gal −) ; CMAH −/− ( Neu5Gc − ); β4GALNT2 −/− ( Sd(a) − ) ; hCD55; hCD39 into a non-human primate (NHP) model of acute hemorrhage hemolysis and evaluated the long-term immune response to xenogeneic RBCs in the liver, a key organ for RBC metabolism. Immediately after xenotransfusion (D + 1), significant elevations of liver enzymes (AST, ALT) and iron-related factors were observed in the serum levels of the recipients, which were normalized by D + 21. However, long-term analysis revealed excessive accumulation of iron ions in the liver and decreased expression of antioxidant enzymes. The resulting endoplasmic reticulum stress (increased GRP78/BiP expression), lipid peroxide accumulation, and iron-dependent cell death (ferroptosis) persisted in the liver of the recipient. These results suggest that, beyond gene editing, additional hurdles must be overcome to completely block oxidative stress damage caused by impaired RBC lysis. Notably, transcriptomic and immunohistochemical analyses in the NHP model identified the direct role of ferroptosis in xenotransfusion-induced liver injury. Therefore, we propose that a multilayered approach, including blocking the ROS-Iron axis and administering ferroptosis inhibitors, is needed to ensure long-term safety in the clinical development of xenotransfusion.
- Open Access
- 18 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0334754
In silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches
Background: Cryptosporidium parvum is a waterborne protozoan parasite responsible for diarrheal illness in humans and animals. The lack of effective vaccines and the emergence of antimicrobial resistance underscore the urgent need for novel prophylactic strategies. Methods: A structure-based immunoinformatics approach was used to design a multi-epitope subunit vaccine (MESV) targeting immunogenic regions of C. parvum . Three proteins, Cp15, Cp23, and CpP2, were selected based on antigenicity, non-allergenicity, non-homology with host proteins, and absence of transmembrane domains. B-cell, CD4 + , CD8 + , and IFN-γ-inducing epitopes were identified and screened for high antigenicity, non-allergenicity, and non-toxicity. To enhance immune recognition, the lipoprotein LprA, a TLR2 agonist, was fused at the N-terminus using an EAAAK linker, and a PADRE sequence was added to improve helper T-cell responses. Linkers were applied to ensure proper epitope separation and processing. Population coverage was analyzed to evaluate the distribution of HLA-restricted epitopes across global populations. Structural modeling and flexibility analysis (CABS-flex) were performed to assess construct stability. Interactions with TLR2 and TLR4 were examined via molecular docking and 100-ns molecular dynamics (MD) simulations, with MM-GBSA used to estimate binding free energies. Immune simulations predicted host immune responses, while codon optimization, in silico cloning, and mRNA secondary structure prediction assessed expression and transcript stability. Results: The MESV showed strong binding to TLR2 (−1328.4 kcal/mol) and TLR4 (−1133.3 kcal/mol), with MD simulations confirming stable complexes. Immune simulations indicated robust antibody production, T-cell activation, cytokine release, and dendritic cell recruitment. The vaccine demonstrated global HLA population coverage of 95.92%, with favorable expression and mRNA folding profiles. Conclusion: The MESV construct demonstrated strong immunogenicity, structural stability, and broad population coverage, underscoring its potential as a promising vaccine candidate against C. parvum . Furthermore, experimental validation is warranted to confirm its safety and efficacy.
- 18 November 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (11) , e0334754
Open AccessIn silico design of a multi-epitope vaccine against Cryptosporidium parvum using structural and immunoinformatics approaches
Background: Cryptosporidium parvum is a waterborne protozoan parasite responsible for diarrheal illness in humans and animals. The lack of effective vaccines and the emergence of antimicrobial resistance underscore the urgent need for novel prophylactic strategies. Methods: A structure-based immunoinformatics approach was used to design a multi-epitope subunit vaccine (MESV) targeting immunogenic regions of C. parvum . Three proteins, Cp15, Cp23, and CpP2, were selected based on antigenicity, non-allergenicity, non-homology with host proteins, and absence of transmembrane domains. B-cell, CD4 + , CD8 + , and IFN-γ-inducing epitopes were identified and screened for high antigenicity, non-allergenicity, and non-toxicity. To enhance immune recognition, the lipoprotein LprA, a TLR2 agonist, was fused at the N-terminus using an EAAAK linker, and a PADRE sequence was added to improve helper T-cell responses. Linkers were applied to ensure proper epitope separation and processing. Population coverage was analyzed to evaluate the distribution of HLA-restricted epitopes across global populations. Structural modeling and flexibility analysis (CABS-flex) were performed to assess construct stability. Interactions with TLR2 and TLR4 were examined via molecular docking and 100-ns molecular dynamics (MD) simulations, with MM-GBSA used to estimate binding free energies. Immune simulations predicted host immune responses, while codon optimization, in silico cloning, and mRNA secondary structure prediction assessed expression and transcript stability. Results: The MESV showed strong binding to TLR2 (−1328.4 kcal/mol) and TLR4 (−1133.3 kcal/mol), with MD simulations confirming stable complexes. Immune simulations indicated robust antibody production, T-cell activation, cytokine release, and dendritic cell recruitment. The vaccine demonstrated global HLA population coverage of 95.92%, with favorable expression and mRNA folding profiles. Conclusion: The MESV construct demonstrated strong immunogenicity, structural stability, and broad population coverage, underscoring its potential as a promising vaccine candidate against C. parvum . Furthermore, experimental validation is warranted to confirm its safety and efficacy.